{"id":"W3155125407","doi":"10.1016/s0140-6736(21)00845-x","title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Novo Nordisk","keywords":"Tolerability; Medicine; Semaglutide; Pharmacokinetics; Pharmacodynamics; Concomitant; Pharmacology; Adverse effect; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005545141,0.00015563,0.00108766,0.00004618198,0.00003242315,0.00000806677,0.00009507527,0.00002630377,0.00003291216],"category_scores_gemma":[0.0001032033,0.00009499182,0.0001503969,0.0001051509,0.0001621749,0.00003151031,0.00005196194,0.00005661934,2.192463e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002090422,"about_ca_system_score_gemma":0.00005492534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008028721,"about_ca_topic_score_gemma":0.00002917507,"domain_scores_codex":[0.998728,0.00009379541,0.0005991601,0.0001956537,0.0002082451,0.0001751888],"domain_scores_gemma":[0.9985381,0.0005665214,0.0003505887,0.0003167628,0.0001797562,0.000048314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.96378,0.002907869,0.001375435,0.001788822,0.003016717,0.0000329596,0.0001961809,0.00005143074,0.01553337,0.001628928,0.0008099786,0.008878325],"study_design_scores_gemma":[0.9261215,0.001700325,0.0002993933,0.0001855837,0.003243988,0.000005559212,0.0001844432,0.006352465,0.05900432,0.0001783377,0.002627955,0.00009617579],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885007,0.0008003961,0.001178077,0.00157173,0.0001398961,0.005065546,0.0002695215,0.00001723438,0.002456895],"genre_scores_gemma":[0.9954945,0.0009750739,0.002561552,0.0001200323,0.0001605364,0.0001738924,0.0001102297,0.0000141147,0.0003900062],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04347095,"threshold_uncertainty_score":0.3873654,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02132443635642622,"score_gpt":0.3119172657700074,"score_spread":0.2905928294135812,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}